Tizanidine Hcl Capsule
Product Images NDC 80425-0144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

Fig 1
A line graph depicting plasma Tizanidine concentration (ng/mL) over time (hours) following dosing. The graph compares concentrations of 2 x 4 mg Tizanidine tablets and capsules, both with and without food, showing absorption and decline patterns over 24 hours.*
FDA Label Image

Fig 2

Fig 2
A line graph showing improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis represents improvement in Ashworth Score, and the horizontal axis shows hours post-dose up to 6 hours. Data points include error bars illustrating variability.*
FDA Label Image

Fig 3

Fig 3
A line graph showing improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) and placebo. The X-axis represents time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The Y-axis shows improvement scores ranging from -6 to 2. Tizanidine consistently shows greater improvement compared to placebo at all time points, with error bars indicating variability.*
FDA Label Image

Structure

Structure
Chemical structure of Tizanidine HCL showing a chlorinated heterocyclic ring fused to a thiazole and an imidazoline moiety, with an attached hydrochloride group.*
FDA Label Image

Tizanidine HCl 4mg Cap Qty 60 Ndc 80425 0144

Tizanidine HCl 4mg Cap Qty 60 Ndc 80425 0144
Label for Tizanidine HCL 4 mg capsules, showing packaging by Advanced Rx Pharmacy of Tennessee, LLC, Nashville, TN. Includes NDC 80425-0144-02, source NDC 67877-0611-15, lot number, expiration date 7/31/2022, and storage instructions 20° to 25°C (68° to 77°F). Contains barcode and federal transfer caution statement.*
FDA Label Image

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0144

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0144
Label for Tizanidine HCL 4 mg capsules from Advanced Rx Pharmacy of Tennessee, LLC. Includes product name, strength, capsule dosage form, NDC 80425-0144-03, source NDC 67837-0611-15, lot number, expiration date, manufacturer Ascend Laborato, storage instructions, barcode, and a federal warning about prescription transfer.*
FDA Label Image

Tizanidine HCl 4mg Tab Qty 30 Ndc 80425 0144

Tizanidine HCl 4mg Tab Qty 30 Ndc 80425 0144
Packaging label for Tizanidine HCL 4 mg capsules, quantity 30, from Advanced Rx Pharmacy of Tennessee, LLC. The label includes the brand comparison to Zanaflex, NDC 80425-0144-01, a barcode with a serial number, and storage instructions to keep at room temperature 20-25°C (68-77°F). Location and lot information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.